In Phase II Clinical Trials
Development of Effective and Innovative Medicines to Address the needs of Patients and Improve their Health, Longevity and Quality of Life.
Hub Controls
  • Control Panel Demo
  • Upload Photo
  • Edit Company Profile
  • Add a Link
  • Update Fast Facts
  • Add Management Bios
  • Private Messages
  • Edit Your Profile

Email Updates

AlphaRx > Message
Generic_profile

Re: FORM 8-K $500,000 unregistered common stock sold

Posted by: AGORACOM on November 30, 2007 01:46PM

In response to: FORM 8-K $500,000 unregiste... by jackfree

Jackfree,

Thank you for your inquiry. The common stock sold as part of the units, including those issuable upon the exercise of the warrants, cannot be re-sold in the public markets unless and until either (a) a registration statement has been filed and declared effective by the U.S. Securities and Exchange Commission covering such shares of common stock or (b) an exemption from the registration requirements of the Securities Act of 1933 is available for their resale.

AlphaRx will not file a registration statement covering such common stock with the U.S. Securities and Exchange Commission


Regards,

AGORACOM

Post a Reply

Please login to reply to this message.

Executive Address
Alrxsmall
Michael Lee
President
May 18, 2006

 

Michael Lee provides the investor community an update on recent events

View Broadcast

Stock Quote